A detailed history of Fayez Sarofim & CO transactions in Hca Healthcare, Inc. stock. As of the latest transaction made, Fayez Sarofim & CO holds 626 shares of HCA stock, worth $227,338. This represents 0.0% of its overall portfolio holdings.

Number of Shares
626
Previous 816 23.28%
Holding current value
$227,338
Previous $272,000 26.1%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$297.0 - $343.29 $56,430 - $65,225
-190 Reduced 23.28%
626 $201,000
Q4 2023

Feb 14, 2024

SELL
$221.81 - $275.85 $63,659 - $79,168
-287 Reduced 26.02%
816 $220,000
Q3 2022

Nov 14, 2022

BUY
$165.99 - $222.36 $183,086 - $245,263
1,103 New
1,103 $203,000
Q2 2022

Aug 12, 2022

SELL
$168.06 - $275.16 $185,370 - $303,501
-1,103 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$157.02 - $191.82 $173,193 - $211,577
1,103 New
1,103 $208,000

Others Institutions Holding HCA

About HCA Healthcare, Inc.


  • Ticker HCA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 287,024,992
  • Market Cap $104B
  • Description
  • HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surger...
More about HCA
Track This Portfolio

Track Fayez Sarofim & CO Portfolio

Follow Fayez Sarofim & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fayez Sarofim & CO, based on Form 13F filings with the SEC.

News

Stay updated on Fayez Sarofim & CO with notifications on news.